tirzepatide for mcas mast cell IV Quercetin Therapy in Stamford, CT MCAS: 3 Conditions Associated With – Not all GLP-1s work the

[5] Unknown Long-Term Consequences The most significant concern is that Ozempic overall is still a relatively new drug, particularly in the context of long-term, non-diabetic use for weight management

Tirzepatide may more-likely cause diabetic retinopathy

It works on two hormone pathways (GLP-1 and GIP) instead of one, and clinical trials show it outperforms semaglutide on average weight loss

If youre considering these treatments, consult with our team to determine which option is the right fit for your health profile

The risk was 0.2% in people taking GLP-1s and 0.1% in those who didnt

Eguia RT, Crawford K, Stevens-Ayers T, Kelnhofer-Millevolte L, Greninger AL, Englund JA, et al